Comparison of quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation

O Manuel, A Humar, J Preiksaitis, K Doucette, S Shokoples, Anton Yariv Peleg, I Cobos, Deepali Kumar

Research output: Contribution to journalArticleResearchpeer-review

103 Citations (Scopus)


Screening for latent tuberculosis infection (LTBI) is recommended prior to organ transplantation. The Quantiferon-TB Gold assay (QFT-G) may be more accurate than the tuberculin skin test (TST) in the detection of LTBI. We prospectively compared the results of QFT-G to TST in patients with chronic liver disease awaiting transplantation. Patients were screened for LTBI with both the QFT-G test and a TST. Concordance between test results and predictors of a discordant result were determined. Of the 153 evaluable patients, 37 (24.2 ) had a positive TST and 34 (22.2 ) had a positive QFT-G. Overall agreement between tests was 85.1 (kappa= 0.60, p <0.0001). Discordant test results were seen in 12 TST positive/QFT-G negative patients and in 9 TST negative/QFT-G positive patients. Prior BCG vaccination was not associated with discordant test results. Twelve patients (7.8 ), all with a negative TST, had an indeterminate result of the QFT-G and this was more likely in patients with a low lymphocyte count (p = 0.01) and a high MELD score (p = 0.001). In patients awaiting liver transplantation, both the TST and QFT-G were comparable for the diagnosis of LTBI with reasonable concordance between tests. Indeterminate QFT-G result was more likely in those with more advanced liver disease.
Original languageEnglish
Pages (from-to)2797 - 2801
Number of pages5
JournalAmerican Journal of Transplantation
Issue number12
Publication statusPublished - 2007
Externally publishedYes

Cite this